Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1895 of 6351
-
Lung transplant showdown: which surgical method wins?
Disease control Recruiting nowThe purpose of this research study is to compare the technique of performing bilateral lung transplantation off-pump vs venoarterial ECMO (VA ECMO). The goal of the trial is to determine which technique has lower rates of primary graft dysfunction.
Sponsor: Mayo Clinic • Aim: Disease control
Last updated Sep 09, 2026 23:00 UTC
-
New lupus drug enpatoran tested for long-term safety
Disease control OngoingThe purpose of the study is to evaluate the long term safety and efficacy of orally administered M5049 in participants with subacute cutaneous lupus erythematosus (SCLE), discoid lupus erythematosus (DLE) and/or systemic lupus erythematosus (SLE) who have completed the 24 week tr…
Phase 2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can HIV status change TB treatment success? a zambian study investigates
Knowledge-focused OngoingThe overarching objective/aim of the study is to assess pulmonary TB treatment and longer-term outcomes among people with and without HIV in African population in order to inform policy and practice around TB treatment and create a platform for additional TB research in Zambia
Sponsor: Centre for Infectious Disease Research in Zambia • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
New vaccine strategy could shield spleenless patients from deadly infection
Disease control Recruiting nowThe purpose of the study is to evaluate the immunological response and tolerance of 3 vaccine strategies against meningococcus B, a potentially fatal invasive infection.
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New knee injection shows promise for arthritis pain relief
Symptom relief CompletedAn open-label, single-arm clinical trial to confirm the safety of monoarticular injections or bi-lateral intra-articular injections of RTX-GRT7039 in patients who have pain associated with osteoarthritis of the knee despite standard of care.
Phase 3 • Sponsor: Grünenthal GmbH • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Iodine gel may stop cavities from coming back in kids
Prevention Recruiting nowThis is a single center, randomized, double-blind, placebo-controlled Phase II clinical trial (RCT) to evaluate the efficacy of topical 10% Polyvinylpyrrolidone-Iodine (PVPI) to prevent new caries lesions when applied to the teeth of children with Severe Early Childhood Caries (S…
Phase 2 • Sponsor: University of Rochester • Aim: Prevention
Last updated Jun 27, 2026 09:09 UTC
-
New implant offers hope for glaucoma patients failing drops
Disease control OngoingThe objective of this early feasibility clinical study is to evaluate the safety and effectiveness of several different GORE Glaucoma Drainage Implant configurations in subjects with primary open-angle glaucoma that is uncontrolled by hypotensive medications or for which conventi…
Sponsor: W.L.Gore & Associates • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New chemo cocktail aims to tame tough childhood kidney cancer
Disease control Recruiting nowThis is a multicenter, interventional, non-randomized study among patients with a relapsed or refractory Wilms tumor. The study will aim to assess efficacy of metronomic chemotherapy, in terms of disease control after two cycles of metronomic chemotherapy.
Phase 1/2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Monkeypox vaccine immune response under the microscope
Knowledge-focused Recruiting nowThis observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC
-
New app aims to help smokers kick the habit for good
Symptom relief CompletedOver 470,000 tobacco users have been served by the Oklahoma Tobacco Helpline (OTH). The OTH reaches a substantial number of smokers each year, but follow-up rates are notoriously low and many smokers may prefer smartphone-based smoking cessation interventions rather than web- or …
Sponsor: University of Oklahoma • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Can the HPV vaccine stop the virus in its tracks? new study aims to find out
Disease control Recruiting nowThis is a non-randomized, open label study to assess the reduction of Human Papillomavirus (HPV) infectivity and transmission in women positive for HPV16 and/or 18 in a cervical, oral and anal sample and vaccinated with 9vHPV/Gardasil-9™. The primary objective of the study is to…
Phase 4 • Sponsor: Miquel Angel Pavon Ribas • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Glass dressing aims to heal diabetic foot ulcers faster
Disease control CompletedThis study is a prospective, multi-center, randomized controlled trial designed to collect patient outcome data on 2 commercially available treatments for diabetic foot wounds.
Sponsor: ETS Wound Care, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New drug aims to ease social struggles in autism
Symptom relief CompletedML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of soci…
Phase 2 • Sponsor: MapLight Therapeutics • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
New oil could boost liver cancer treatment
Disease control Stopped earlyThe phase I/II, double-blind, randomized study will investigate the efficacy and safety of TACE/TAE treatment with T-ACE Oil in patients with unresectable hepatocellular carcinoma.
Phase 1/2 • Sponsor: T-ACE Medical Co., Ltd • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can botox calm the jaw and face muscles that Won't relax?
Symptom relief CompletedThis study evaluates the effectiveness and safety of Electromyography (EMG)-guided Botulinum Toxin type A (BTX-A) injections in treating oromandibular dystonia (OMD) among a sample of Yemeni patients. Oromandibular dystonia is a neurological movement disorder characterized by inv…
Phase 1 • Sponsor: Sana'a University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New drug R289 offers hope for blood disorder patients who failed other therapies
Disease control Recruiting nowPhase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)
Phase 1/2 • Sponsor: Rigel Pharmaceuticals • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New adaptive radiotherapy aims to shrink treatment margins for uterine cancers
Disease control CompletedOnline adaptive radiotherapy has demonstrated to be feasible to reduce inter-fractional radiotherapy errors as it re-optimizes treatment plan every fraction. To investigate the extent and value of margin reduction,we conduct a prospective clinical trial to determine the optimal m…
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Can a talking therapy tame tics? new study recruits 200 kids
Symptom relief Recruiting nowThe purpose of this protocol is to examine treatment outcomes of youth receiving the Comprehensive Behavioral Intervention for Tics (CBIT) and better understand the predictors, moderators, mediators and/or mechanisms of change for this intervention.
Sponsor: University of Miami • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a smaller dose of monkeypox vaccine work just as well?
Vaccine CompletedThis study is a Phase 2 randomized, open-label, non-placebo controlled, multi-site clinical trial that will evaluate two intradermal (ID) regimens for Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine compared to the standard subcutaneous (SC) regimen in healthy, vaccinia…
Phase 2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Jun 27, 2026 12:08 UTC
-
Can a simple test strip save lives? ohio study aims to find out
Knowledge-focused OngoingThe purpose of the study is to investigate the feasibility, acceptability, and associated benefits and harms of integrating FTS education and distribution into select Project DAWN sites in rural and urban communities in Ohio.
Sponsor: Nationwide Children's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:39 UTC